The North America Healthcare contract research organizations (CRO) services market is expected to reach US$ 40,863.26 million by 2027 from US$ 19,498.79 million in 2019; it is estimated to grow at a CAGR of 9.9% from 2020 to 2027.
The growth of the North America healthcare contract research organizations (CRO) services market is mainly attributed as growing number of clinical trials and increasing expenditure in R&D and outsourcing activities in the country. However, the stringent regulations for approval of drugs is the major factor hindering the market growth in North America.Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards.
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; also, they extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial potential. In addition, R&D spending by biopharmaceutical companies has increased over the years. For instance, according to a study published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of biopharmaceutical companies grew from US$ 49.6 billion in 2012 to US$ 79.6 billion in 2018. Such massive investments in R&Ds are likely to drive the contract research organization services market during the forecast period.
Contract research organizations assist the sponsor companies in terms of research, development, and commercialization of new therapeutic products, especially in pharmaceutical, biopharmaceutical, and medical device industries. Many companies are also coming forward to establish strategic partnership with contract research organizations. For instance, in January 2020, Aragen Bioscience, Inc, a subsidiary of GVK BIO, one of the significant players in pre-clinical CRO, entered into a strategic collaboration with Serum Institute of India Pvt. Ltd. to accelerate the R&D of multiple stable cell lines under Serum’s HIV program. Further, in April 2020, ICON plc. signed a three-year strategic agreement with Pfizer Inc. to provide expertise in planning and management, as well as execution of clinical trials. Such collaborations and partnerships indicate the preference of pharmaceutical companies to prefer contract research organizations to conduct research activities, which will eventually fuel the market growth.
North America is witnessing the growing number of COVID-19 cases. Due to the outbreak of COVID-19 pandemic there is an increased need for therapeutic or vaccine for this highly contagious viral disease. Hence, more COVID-19 clinical trials are being planned and initiated, whereas, the large number of clinical trials in US for non- COVID-19 indications are being delayed. Therefore, it is likely to affect the healthcare contract research organizations (CRO) services market owing to the above mention points.
Mexico Healthcare Contract Research Organizations (CRO) Services Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET SEGMENTATION
By Service Type
- Early Phase Development
- Laboratory Services
- Consulting Services
- Clinical Research Services
By Therapeutic Application
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End-User
- Medical Device Companies
- Pharmaceutical and Biopharmaceutical Companies
- Others (Academic Institutes)
By Country
- US
- Canada
- Mexico
Company Profiles
- Charles River Laboratories, Inc.
- IQVIA INC
- Laboratory Corporation of America Holdings (Covance)
- Parexel International Corporation
- PRA Health Sciences
- Syneos Health
- Medpace
- PPD Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
North America Healthcare Contract Research Organizations Services Market Forecast to 2027 - COVID-19 Impact and Regional Analysis byService Type, Therapeutic Indication, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction. 21
1.1 Scope of the Study. 21
1.2 The Insight Partners Research Report Guidance. 21
1.3 Market Segmentation. 23
1.3.1 North America Healthcare contract research organizations (CRO) services Market – By Service Type. 24
1.3.2 North America Healthcare contract research organizations (CRO) services Market – By Therapeutic Indication. 24
1.3.3 North America Healthcare contract research organizations (CRO) services Market – By End User 25
1.3.4 North America Healthcare contract research organizations (CRO) services Market – By Country. 25
2. North America Healthcare contract research organizations (CRO) services Market – Key Takeaways. 26
3. Research Methodology. 30
3.1 Coverage. 31
3.2 Secondary Research. 32
3.3 Primary Research. 33
4. North America Healthcare contract research organizations (CRO) services Market – Market Landscape. 34
4.1 Overview.. 34
4.2 PEST Analysis. 35
4.2.1 Healthcare contract research organizations (CRO) services Market - North America PEST Analysis. 35
4.3 Expert Opinion. 36
5. North America Healthcare Contract Research Organizations (CRO) services Market - Key Market Dynamics. 37
5.1 Key Market Drivers. 37
5.1.1 Increasing Expenditure in R&D and Outsourcing Activities. 37
5.1.1 Rising Number of Clinical Trials. 38
5.2 Key Market Restraints. 39
5.2.1 Stringent Regulations For Approval Of Drugs. 39
5.3 Key Market Opportunities. 39
5.3.1 Rising Biosimilars and Biologics Market 39
5.4 Future Trends. 41
5.4.1 Globalization of Clinical Studies. 41
5.5 Impact Analysis. 42
6. Healthcare Contract Research Organizations (CRO) Services Market – North America Analysis. 43
6.1 North America Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecasts and Analysis. 43
7. North America Healthcare Contract Research Organizations (CRO) Services Market Analysis and Forecasts To 2027 – By Service Type. 44
7.1 Overview.. 44
7.2 North America Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%) 44
7.2.1 North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027, By Service Type (US$ Mn) 45
7.2.2 Clinical-Research Services Market Revenue and Forecasts to 2027 (US$ Million) 46
7.2.3 Early Phase Development Market Revenue and Forecasts to 2027 (US$ Million) 47
7.2.4 Laboratory Services Market Revenue and Forecasts to 2027 (US$ Million) 47
7.3 Early Phase Development 48
7.3.1 Overview.. 48
7.3.2 North America Early Phase Development Market Revenue and Forecast to 2027 (US$ Mn) 48
7.3.3 Discovery Studies. 49
7.3.3.1 Overview.. 49
7.3.3.2 North America Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn) 49
7.3.4 Chemistry, Manufacturing, and Control 51
7.3.4.1 Overview.. 51
7.3.4.2 North America Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn) 51
7.3.5 Pre-Clinical Services. 53
7.3.5.1 Overview.. 53
7.3.5.2 North America Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn) 53
7.4 Laboratory Services. 55
7.4.1 Overview.. 55
7.4.2 North America Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn) 55
7.4.3 Bio-analytical Testing. 56
7.4.3.1 Overview.. 56
7.4.3.2 North America Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 56
7.4.4 Analytical Testing. 57
7.4.4.1 Overview.. 57
7.4.4.2 North America Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 57
7.5 Consulting Services. 58
7.5.1 Overview.. 58
7.5.2 North America Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn) 58
7.6 Clinical Research Services. 59
7.6.1 Overview.. 59
7.6.2 North America Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn) 59
7.6.3 Phase I 61
7.6.3.1 Overview.. 61
7.6.3.2 North America Phase I Market Revenue and Forecasts to 2027 (US$ Mn) 61
7.6.4 Phase II 62
7.6.4.1 Overview.. 62
7.6.4.2 North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 62
7.6.5 Phase III 63
7.6.5.1 Overview.. 63
7.6.5.2 North America Phase III Market Revenue and Forecasts to 2027 (US$ Mn) 63
7.6.6 Phase IV. 64
7.6.6.1 Overview.. 64
7.6.6.2 North America Phase IV Market Revenue and Forecasts to 2027 (US$ Mn) 64
8. North America Healthcare Contract Research Organizations (CRO) Services Market Analysis – By Therapeutic Application. 65
8.1 Overview.. 65
8.2 North America Healthcare Contract Research Organizations (CRO) Services Market, By Therapeutic Application 2019-2027 (%) 65
8.2.1 North America Healthcare Contract Research Organizations (CRO) Services Market Devices Revenue and Forecasts to 2027, By Therapeutic Application (US$ Mn) 67
8.3 Oncology. 68
8.3.1 Overview.. 68
8.3.2 North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn) 68
8.4 Infectious Diseases. 70
8.4.1 Overview.. 70
8.4.2 North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 70
8.5 Cardiovascular Disease. 71
8.5.1 Overview.. 71
8.5.2 North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn) 71
8.6 Respiratory Diseases. 73
8.6.1 Overview.. 73
8.6.2 North America Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 73
8.7 Neurological Disorders. 75
8.7.1 Overview.. 75
8.7.2 North America Neurological Disorders Market Revenue and Forecasts to 2027 (US$ Mn) 75
8.8 Others. 77
8.8.1 Overview.. 77
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn) 78
9. North America Healthcare contract research organizations (CRO) services Market Analysis – By End User. 79
9.1 Overview.. 79
9.2 North America Healthcare contract research organizations (CRO) services Market, By End User 2019-2027 (%) 79
9.2.1 North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts to 2027, By End User (US$ Mn) 81
9.3 Pharmaceutical and Biopharmaceutical Companies. 82
9.3.1 Overview.. 82
9.3.2 North America Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn) 82
9.4 Medical Device Companies. 84
9.4.1 Overview.. 84
9.4.2 North America Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn) 84
9.5 Others (Academic Institutes) 85
9.5.1 Overview.. 85
9.5.2 North America Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn) 85
10. Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027 – Geographical Analysis. 86
10.1 North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027. 86
10.1.1 Overview.. 86
10.1.2 North America: Healthcare Contract Research Organizations (CRO) Services Market-Revenue and Forecasts to 2027 (US$ Million) 88
10.1.3 North America Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 89
10.1.3.1 North America Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 90
10.1.3.2 North America Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 91
10.1.3.3 North America Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 91
10.1.4 North America Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 92
10.1.5 North America Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 93
10.1.6 North America: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%) 94
10.1.7 US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 95
10.1.7.1 US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 96
10.1.8 US Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 96
10.1.8.1 US Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 97
10.1.8.2 US Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 98
10.1.8.3 US Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 99
10.1.9 US Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 100
10.1.10 US Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 101
10.1.11 Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 102
10.1.11.1 Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 103
10.1.12 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 104
10.1.12.1 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 105
10.1.12.2 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 106
10.1.12.3 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 106
10.1.13 Canada Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 107
10.1.14 Canada Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 108
10.1.15 Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 109
10.1.15.1 Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 110
10.1.16 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 111
10.1.16.1 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 112
10.1.16.2 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 112
10.1.16.3 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 113
10.1.17 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 114
10.1.18 Mexico Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 115
11. Impact of COVID-19 Pandemic on North America Healthcare contract research organizations (CRO) services Market 116
11.1 North America: Impact Assessment of COVID-19 Pandemic. 116
12. Company Profiles. 118
12.1 Charles River Laboratories, Inc. 118
12.1.1 Key Facts. 118
12.1.2 Business Description. 118
12.1.3 Products and Services. 119
12.1.4 Financial Overview.. 120
12.1.5 SWOT Analysis. 122
12.1.6 Key Developments. 123
12.2 IQVIA INC. 125
12.2.1 Key Facts. 125
12.2.2 Business Description. 125
12.2.3 Products and Services. 126
12.2.4 Financial Overview.. 127
12.2.5 SWOT Analysis. 129
12.2.6 Key Developments. 130
12.3 Laboratory Corporation of America Holdings(Covance) 131
12.3.1 Key Facts. 131
12.3.2 Business Description. 131
12.3.3 Products and Services. 132
12.3.4 Financial Overview.. 133
12.3.5 SWOT Analysis. 135
12.3.6 Key Developments. 136
12.4 Parexel International Corporation. 137
12.4.1 Key Facts. 137
12.4.2 Business Description. 137
12.4.3 Products and Services. 138
12.4.4 Financial Overview.. 138
12.4.5 SWOT Analysis. 139
12.4.6 Key Developments. 140
12.5 PRA Health Sciences. 141
12.5.1 Key Facts. 141
12.5.2 Business Description. 141
12.5.3 Products and Services. 142
12.5.4 Financial Overview.. 142
12.5.5 SWOT Analysis. 144
12.5.6 Key Developments. 145
12.6 Syneos Health. 146
12.6.1 Key Facts. 146
12.6.2 Business Description. 146
12.6.3 Products and Services. 147
12.6.4 Financial Overview.. 148
12.6.5 SWOT Analysis. 150
12.6.6 Key Developments. 151
12.7 Medpace. 152
12.7.1 Key Facts. 152
12.7.2 Business Description. 152
12.7.3 Products and Services. 153
12.7.4 Financial Overview.. 153
12.7.5 SWOT Analysis. 155
12.7.6 Key Developments. 155
12.8 PPD Inc. 156
12.8.1 Key Facts. 156
12.8.2 Business Description. 156
12.8.3 Products and Services. 157
12.8.4 Financial Overview.. 157
12.8.5 SWOT Analysis. 159
12.8.6 Key Developments. 160
13. Appendix. 161
13.1 About The Insight Partners. 161
13.2 Glossary of Terms. 161
LIST OF TABLES
Table 1. Number of registered Studies For Clinical Trials. 38
Table 2. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Service Type (US$ Mn) 46
Table 3. Clinical-Research Services Market Revenue And Forecasts to 2027 (US$ Million) 46
Table 4. Early Phase Development Market Revenue And Forecasts to 2027 (US$ Million) 47
Table 5. Laboratory Services Market Revenue And Forecasts to 2027 (US$ Million) 47
Table 6. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Therapeutic Application (US$ Mn) 67
Table 7. North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027, By End User (US$ Mn) 81
Table 8. North America Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 89
Table 9. North America Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 90
Table 10. North America Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 91
Table 11. North America Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 91
Table 12. North America Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 92
Table 13. North America Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 93
Table 14. US Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 97
Table 15. US Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 97
Table 16. US Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 98
Table 17. US Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 99
Table 18. US Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 100
Table 19. US Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 101
Table 20. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 104
Table 21. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 105
Table 22. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 106
Table 23. Canada Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 106
Table 24. Canada Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 107
Table 25. Canada Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 108
Table 26. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 111
Table 27. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 112
Table 28. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 112
Table 29. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 113
Table 30. Mexico Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 114
Table 31. Mexico Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 115
Table 32. Glossary of Terms, Healthcare Contract Research Organizations (CRO) Services Market 161
LIST OF FIGURES
Figure 1. Healthcare contract research organizations (CRO) services Market Segmentation. 23
Figure 2. North America Healthcare contract research organizations (CRO) services Market Overview.. 26
Figure 3. Clinical Research Services Segment Held Largest Share of Healthcare Contract Research Organizations (CRO) Services Market 27
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period. 28
Figure 5. North America Healthcare contract research organizations (CRO) services Market - Leading Country Markets (US$ Mn) 29
Figure 6. Healthcare contract research organizations (CRO) services Market - North America PEST Analysis. 35
Figure 1. Number of Approvals for NDA and BLA (2005 to 2019) 40
Figure 2. Healthcare contract research organizations (CRO) services Market Impact Analysis of Driver and Restraints. 42
Figure 3. North America Healthcare Contract Research Organizations (CRO) Services market – Revenue Forecasts and Analysis – 2019- 2027. 43
Figure 4. North America Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%) 45
Figure 5. North America Early Phase Development Market Revenue and Forecasts to 2027 (US$ Mn) 48
Figure 6. North America Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn) 50
Figure 7. North America Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn) 52
Figure 8. North America Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn) 54
Figure 9. North America Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn) 55
Figure 10. North America Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 56
Figure 11. North America Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 57
Figure 12. North America Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn) 58
Figure 13. North America Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn) 60
Figure 14. North America Phase I Market Revenue and Forecasts to 2027 (US$ Mn) 61
Figure 15. North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 62
Figure 16. North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 63
Figure 17. North America Phase IV Market Revenue and Forecasts to 2027 (US$ Mn) 64
Figure 18. North America Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Application 2019 & 2027 (%) 66
Figure 19. North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn) 69
Figure 20. North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 70
Figure 21. North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn) 72
Figure 22. North America Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 74
Figure 23. North America Neurological Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 76
Figure 24. North America Others Market Revenue and Forecasts to 2027 (US$ Mn) 78
Figure 25. North America Healthcare contract research organizations (CRO) services Market, by End User 2019 & 2027 (%) 80
Figure 26. North America Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83
Figure 27. North America Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn) 84
Figure 28. North America Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn) 85
Figure 29. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue, by Country, 2019 (US$ Mn) 87
Figure 30. North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Million) 88
Figure 31. North America: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%) 94
Figure 32. US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 96
Figure 33. Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 103
Figure 34. Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 110
Figure 35. Impact of COVID-19 Pandemic in North American Country Markets. 117
- Charles River Laboratories, Inc.
- IQVIA INC
- Laboratory Corporation of America Holdings (Covance)
- Parexel International Corporation
- PRA Health Sciences
- Syneos Health
- Medpace
- PPD Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Healthcare Contract Research Organizations (CRO) Services Market
Aug 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)